Symptomatic Improvement Within 3 Days With Tofacitinib Induction Therapy in Patients With Ulcerative Colitis: Results From OCTAVE Induction 1 and 2

被引：0
|
作者：
Hanauer, Stephen [1 ]
Panaccione, Remo [2 ]
Danese, Silvio [3 ]
Cheifetz, Adam [4 ,5 ,6 ]
Reinisch, Walter [7 ]
Higgins, Peter D. R. [8 ]
Woodworth, Deborah A. [9 ]
Zhang, Haiying [9 ]
Friedman, Gary S. [9 ]
Lawendy, Nervin [9 ]
Quirk, Daniel [9 ]
Nduaka, Chudy I. [9 ]
Su, Chinyu [9 ]
机构：
[1] Northwestern Univ, Feinberg Sch Med, Evanston, IL USA
[2] Univ Calgary, Dept Med, Calgary, AB, Canada
[3] Humanitas Clin & Res Ctr, Rozzano, Lombardia, Italy
[4] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA
[5] Beth Israel Deaconess Med Ctr, Div Gastroenterol, Boston, MA 02215 USA
[6] Harvard Med Sch, Boston, MA USA
[7] Med Univ Vienna, Hamilton, ON, Canada
[8] Univ Michigan, Ann Arbor, MI 48109 USA
[9] Pfizer Inc, Collegeville, PA USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2017年 / 112卷
关键词：
D O I：
10.14309/00000434-201710001-00609
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
609
引用
收藏
页码：S331 / S331
页数：1
相关论文
共 50 条
  • [1] Tofacitinib Induction Therapy Reduces Symptoms Within 3 Days for Patients With Ulcerative Colitis
    Hanauer, Stephen
    Panaccione, Remo
    Danese, Silvio
    Cheifetz, Adam
    Reinisch, Walter
    Higgins, Peter D. R.
    Woodworth, Deborah A.
    Zhang, Haiying
    Friedman, Gary S.
    Lawendy, Nervin
    Quirk, Daniel
    Nduaka, Chudy I.
    Su, Chinyu
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (01) : 139 - 147
  • [2] Tofacitinib achieves symptomatic improvement within 3 days in moderately to severely active ulcerative colitis, regardless of prior tumour necrosis factor inhibitor treatment status: results from OCTAVE induction 1 and 2
    Hanauer, S.
    Panaccione, R.
    Danese, S.
    Cheifetz, A.
    Reinisch, W.
    Higgins, P. D. R.
    Woodworth, D. A.
    Zhang, H.
    Friedman, G. S.
    Lawendy, N.
    Quirk, D.
    Nduaka, C. I.
    Su, C.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S46 - S48
  • [3] TOFACITINIB ACHIEVES SYMPTOMATIC IMPROVEMENT WITHIN 3 DAYS IN MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS, REGARDLESS OF PRIOR TUMOUR NECROSIS FACTOR INHIBITOR TREATMENT STATUS: RESULTS FROM OCTAVE INDUCTION 1 & 2
    Hanauer, Stephen B.
    Panaccione, Remo
    Danese, Silvio
    Cheifetz, Adam S.
    Reinisch, Walter
    Higgins, Peter D.
    Woodworth, Deborah A.
    Zhang, Haiying
    Friedman, Gary S.
    Lawendy, Nervin
    Quirk, Daniel
    Nduaka, Chudy I.
    Su, Chinyu
    GASTROENTEROLOGY, 2018, 154 (06) : S381 - S382
  • [4] Symptomatic Improvement Observed Within 2 Days of Etrasimod Induction Therapy: Results From ELEVATE UC 52 and ELEVATE UC 12 Studies in Patients With Ulcerative Colitis
    Dubinsky, Marla C.
    Vermeire, Severine
    Chaparro, Maria
    Irving, Peter M.
    Bartolome, Lauren
    Woolcott, John C.
    Rabbat, Christopher J.
    Wang, Wenjin
    Goetsch, Martina
    Torres, Joana
    Panaccione, Remo
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S623 - S623
  • [5] Tofacitinib 15 Milligrams Twice Daily for Patients With Moderate to Severe Ulcerative Colitis: Results From 8-Week Induction Studies OCTAVE Induction 1 & 2
    Rubin, David T.
    Motoya, Satoshi
    Schreiber, Stefan
    Quirk, Daniel
    Nduaka, Chudy I.
    Lawendy, Nervin
    Woodworth, Deborah A.
    Wang, Wenjin
    Su, Chinyu
    Higgins, Peter D. R.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S403 - S403
  • [6] Ulcerative colitis: Induction Therapy effective with Tofacitinib
    Kessing, Richard
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2019, 57 (05): : 556 - 556
  • [7] Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis
    Dai, Cong
    Jiang, Min
    Sun, Ming-Jun
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (05): : 496 - 496
  • [8] Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis
    Sandborn, William J.
    Su, Chinyu
    Sands, Bruce E.
    D'Haens, Geert R.
    Vermeire, Severine
    Schreiber, Stefan
    Danese, Silvio
    Feagan, Brian G.
    Reinisch, Walter
    Niezychowski, Wojciech
    Friedman, Gary
    Lawendy, Nervin
    Yu, Dahong
    Woodworth, Deborah
    Mukherjee, Arnab
    Zhang, Haiying
    Healey, Paul
    Panes, Julian
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (18): : 1723 - 1736
  • [9] Tofacitinib in Ulcerative Colitis: The Relationship Between OCTAVE Induction Week 8 Symptomatic Remission and OCTAVE Sustain Week 52 Remission
    Desreumaux, Pierre
    Akyuz, Filiz
    Ha, Christina
    Bouzidi, Amira
    Tamzali, Amel
    Gardiner, Sean
    Wu, Joseph
    Paulissen, Jerome
    Vuitton, Lucine
    Regueiro, Miguel
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S913 - S914
  • [10] Tofacitinib induction therapy in ulcerative colitis can be prolonged
    Di Lellis, Maddalena Angela
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2022, 60 (12): : 1742 - +
12345